US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Research & Development Market Research Reports & Industry Analysis

The term research and development (R&D) refers to work that is done in order to better understand the nature, function or understanding of a topic or product in order to gain knowledge and find new applications for existing products or to develop new and innovative products. This is usually performed by corporations, government agencies, and research or academic institutions.

New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.

Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.

RSS Feeds

Research & Development Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Cystic Fibrosis Market in Europe 2015-2019
2/18/2015 | published by: TechNavio - Infiniti Research Ltd.
... difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic fibrosis is one of the most common genetic disorders observed in Caucasian children. Rare diseases are those that affect ...  |  read more...
USD 3,000
Global Infertility Market 2015-2019
2/18/2015 | published by: TechNavio - Infiniti Research Ltd.
... infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors ...  |  read more...
USD 2,500
Drivers for Healthcare R&D Investment in Asia-Pacific
1/22/2015 | published by: Frost & Sullivan
... reasons that have transformed the APAC region into a preferred R&D investment destination. We highlight four countries—China, Singapore, South Korea, and Taiwan—which showed the highest increase in R&D investment between 2009 and 2012. Driven by ...  |  read more...
USD 2,000
A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market
1/28/2015 | published by: Frost & Sullivan
... large pharmaceutical (pharma) participants such as Merck, AstraZeneca, Eli Lilly, and Bristol-Myers Squibb (BMS), which are set to launch their targeted therapy drugs. BMS has already launched Opdivo (Nivolumab) in Japan (July 2014), and became ...  |  read more...
USD 5,000
Oral Proteins and Peptides Market (2nd Edition), 2015 – 2025
1/27/2015 | published by: Roots Analysis
... delivery is the more preferred route. Although very convenient, there are many challenges which hinder this route of administration. These include enzymatic and pH-dependent degradation of the amino acid based drugs in the gastrointestinal tract, ...  |  read more...
USD 1,899
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome). A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for ...  |  read more...
USD 2,000
Analyzing the Global Pharmaceutical Industry 2015
2/1/2015 | published by: Aruvian's R'search
... garner increased revenues with intercontinental treatment demand of patients being serviced from often one or two mega research centers in the continent. By contribution of size, the pharmaceutical industry is majorly dominant at the US, ...  |  read more...
USD 2,500
Global Cystic Fibrosis Industry 2014 Market Research Report
1/20/2015 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Cystic Fibrosis basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Global CRO Market
2/4/2015 | published by: Frost & Sullivan
... of the global CRO market stood at ??% in 2014 against the potential outsourcing market, providing a huge opportunity for CRO companies to increase their market share. The share of services, such as Data Management, ...  |  read more...
USD 10,000
Global Atrial Fibrillation Market 2015-2019
1/28/2015 | published by: TechNavio - Infiniti Research Ltd.
... type of arrhythmia of the heart, superventricular tachycardia. The chief difference between these two types of arrhythmia is the consistency of the beats. In superventricular tachycardia, the heart beats are regular and at a very ...  |  read more...
USD 2,500
Global Pharma US & EU Outlook 2015 : First –In- Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies
1/26/2015 | published by: MP Advisors
... non-core assets resulting in healthy Cash position- Will accelerate Next wave of targeted acquisition In the recent years several new therapies have been approved in the area of diabetes (SGLT-2, GLP-1 agonists), Multiple Sclerosis, HCV, ...  |  read more...
USD 2,000
Active Pharmaceutical Ingredients (API) Market in the US 2015-2019
2/4/2015 | published by: TechNavio - Infiniti Research Ltd.
... benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology ...  |  read more...
USD 2,500
Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... line of therapy. Given the fact that they all target tyrosine kinases and that kinase mutations can cause patients to become resistant to these drugs, there is plenty of room for more competition. There are ...  |  read more...
USD 6,746
Proteins in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 200 drugs. Proteins In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis ...  |  read more...
USD 6,746
RANKL Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... function. Binding of RANKL to RANK leads to the activation of signaling modules such as NF-kappa B, mitogen activated protein kinases (MAPK's), protein kinase C (PKC), Ca2+/Calcineurin/nuclear factor of activated T cells (NFAT) and phosphatidyl ...  |  read more...
USD 6,746
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... RNA (miRNA, RNAi & siRNA) drugs in 152 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 28 drugs. ...  |  read more...
USD 4,496
TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... 6 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 295 drugs. Tnf-Alpha Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress ...  |  read more...
USD 6,746
Global Orphan Drugs Industry 2014 Market Research Report
1/10/2015 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Orphan Drugs basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Global Ankylosing Spondylitis Market 2015-2019
1/7/2015 | published by: TechNavio - Infiniti Research Ltd.
... Ankylosing spondylitis can be diagnosed using clinical signs, radiological signs (sacroiliitis) and the presence of HLA-B27 antigen. According to the NIH and NIAMS, ankylosing spondylitis is a type of arthritis, which affects the joints in ...  |  read more...
USD 3,000
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... and the accumulated number of ceased drugs over the last years amount to another 249 drugs. Androgen Receptor Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on ...  |  read more...
USD 6,746
Hepatitis C Therapies: World Industry, R&D and Market Forecasts 2015-2025
12/12/2014 | published by: Visiongain
... Now you can get sales forecasts and explore that industry’s research and development. See where the money lies from 2014. And find where that technology heads. Visiongain’s new guide predicts those revenues to 2025 at ...  |  read more...
USD 2,788
Angiogenesis in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... amount to another 207 drugs. Angiogenesis In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 277 different targets. All included ...  |  read more...
USD 6,746
Antibodies in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... of therapeutic antibodies. There are today 354 companies plus partners developing 707 antibody drugs in 1875 developmental projects in cancer. In addition, there are 6 suspended drugs and the accumulated number of ceased drugs over ...  |  read more...
USD 6,746
Biologicals in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... in cancer. In addition, there are 26 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 1009 drugs. Biologicals In Oncology Drug Pipeline Update lists all drugs and ...  |  read more...
USD 11,246
Breast Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... below five years. There are today 400 companies plus partners developing 540 drugs targeting breast cancer in development. In addition, there are 8 suspended drugs and the accumulated number of ceased drugs over the last ...  |  read more...
USD 6,746
< prev 1    3  4  5  6  7  8  9  10